The evolution of mendelian randomization for investigating drug effects
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.
Description
Is Part Of
Publisher
Public Library of Science
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/